$WVE
Wave Life Sciences Ltd.

2016 Q1 Form 10-K Financial Statement

#000119312516523890 Filed on March 30, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 2014 Q4
Revenue $0.00 $152.0K $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.220M $10.39M $1.060M
YoY Change 71.28% 246.33%
% of Gross Profit
Research & Development $4.736M $9.057M $720.0K
YoY Change 194.71% 278.16%
% of Gross Profit
Depreciation & Amortization $153.0K $590.0K $80.00K
YoY Change 70.0% 110.71%
% of Gross Profit
Operating Expenses $7.952M $19.45M $1.780M
YoY Change 127.79% 260.59%
Operating Profit -$7.952M -$19.30M
YoY Change 129.49% 257.77%
Interest Expense $104.0K $86.00K
YoY Change -816.67%
% of Operating Profit
Other Income/Expense, Net $100.0K $142.0K $20.00K
YoY Change 100.0% -42.97%
Pretax Income -$7.852M -$19.16M -$1.760M
YoY Change 129.93% 272.32%
Income Tax -$5.000K $44.00K -$10.00K
% Of Pretax Income
Net Earnings -$7.847M -$19.20M -$1.749M
YoY Change 126.46% 267.18%
Net Earnings / Revenue -12631.58%
Basic Earnings Per Share
Diluted Earnings Per Share -$364.3K -$1.829M -$83.61K
COMMON SHARES
Basic Shares Outstanding 21.55M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $153.4M $161.2M $1.000M
YoY Change 16020.0%
Cash & Equivalents $153.4M $161.2M $1.048M
Short-Term Investments
Other Short-Term Assets $600.0K $100.0K $200.0K
YoY Change -50.0%
Inventory
Prepaid Expenses
Receivables $0.00 $200.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $154.0M $161.4M $1.487M
YoY Change 10660.0%
LONG-TERM ASSETS
Property, Plant & Equipment $3.218M $2.800M $1.269M
YoY Change 115.38% -8.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.300M $1.300M $200.0K
YoY Change 550.0%
Total Long-Term Assets $4.522M $4.000M $1.451M
YoY Change 185.71%
TOTAL ASSETS
Total Short-Term Assets $154.0M $161.4M $1.487M
Total Long-Term Assets $4.522M $4.000M $1.451M
Total Assets $158.5M $165.4M $2.938M
YoY Change 5603.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.437M $2.800M $125.0K
YoY Change 2700.0%
Accrued Expenses $1.300M $600.0K $400.0K
YoY Change 50.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $100.0K $0.00
YoY Change
Total Short-Term Liabilities $3.770M $3.800M $882.0K
YoY Change 322.22%
LONG-TERM LIABILITIES
Long-Term Debt $100.0K $100.0K $0.00
YoY Change
Other Long-Term Liabilities $295.0K $200.0K $29.00K
YoY Change
Total Long-Term Liabilities $357.0K $300.0K $29.00K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.770M $3.800M $882.0K
Total Long-Term Liabilities $357.0K $300.0K $29.00K
Total Liabilities $4.127M $4.100M $911.0K
YoY Change 355.56%
SHAREHOLDERS EQUITY
Retained Earnings -$42.92M -$15.88M
YoY Change
Common Stock $185.3M $9.973M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $146.5M $161.4M $2.027M
YoY Change
Total Liabilities & Shareholders Equity $158.5M $165.4M $2.938M
YoY Change 5603.45%

Cashflow Statement

Concept 2016 Q1 2015 2014 Q4
OPERATING ACTIVITIES
Net Income -$7.847M -$19.20M -$1.749M
YoY Change 126.46% 267.18%
Depreciation, Depletion And Amortization $153.0K $590.0K $80.00K
YoY Change 70.0% 110.71%
Cash From Operating Activities -$7.140M -$12.53M -$1.240M
YoY Change 340.74% 182.84%
INVESTING ACTIVITIES
Capital Expenditures $685.0K $1.857M -$30.00K
YoY Change 3929.41% 214.75%
Acquisitions
YoY Change
Other Investing Activities -$1.050M $20.00K
YoY Change -418.18%
Cash From Investing Activities -$690.0K -$2.910M -$10.00K
YoY Change 885.71% 1019.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $11.63M
YoY Change 108.25%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -20.00K 175.6M 0.000
YoY Change -100.17% 3024.38%
NET CHANGE
Cash From Operating Activities -7.140M -12.53M -1.240M
Cash From Investing Activities -690.0K -2.910M -10.00K
Cash From Financing Activities -20.00K 175.6M 0.000
Net Change In Cash -7.850M 160.2M -1.250M
YoY Change -178.97% 17120.43%
FREE CASH FLOW
Cash From Operating Activities -$7.140M -$12.53M -$1.240M
Capital Expenditures $685.0K $1.857M -$30.00K
Free Cash Flow -$7.825M -$14.39M -$1.210M
YoY Change 378.01% 186.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 wve Minimum Number Of Shares To Be Held To Receive Right To Purchase New Securities
MinimumNumberOfSharesToBeHeldToReceiveRightToPurchaseNewSecurities
1212477 shares
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21551423 shares
CY2015Q3 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
10000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-4579000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
815000
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1209000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
379000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-7762000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
901000
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1534000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1384000
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
0
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
439000
CY2014Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3901348 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4263472 shares
CY2014Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3901348 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4263472 shares
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
29000
CY2014Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
605000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
177000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
315000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
2027000
CY2014Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
29000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1025000
CY2014Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
113000
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
152000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
125000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15876000
CY2014Q4 us-gaap Liabilities
Liabilities
911000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2938000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
9973000
CY2014Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
230000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1209000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
882000
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2658000
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
7874000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
56000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
63000
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
182000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1298000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3134000
CY2014Q4 us-gaap Assets
Assets
2938000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
1295000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
200000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1269000
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
0
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
476000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
1487000
CY2014Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
72000
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
246000
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
94000
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
64000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
103000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1048000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2478000
CY2014Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
384000
CY2014Q4 wve Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
230000
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21551423 shares
CY2015Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21551423 shares
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1030000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
845000
CY2015Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
241000
CY2015Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
945000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
354000
CY2015Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
10000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
9267000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
153491000
CY2015Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
163000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
400000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3182000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1280000
CY2015Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
191000
CY2015Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
997000000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2811000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35076000
CY2015Q4 us-gaap Liabilities
Liabilities
4059000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
165424000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
185344000
CY2015Q4 dei Entity Public Float
EntityPublicFloat
0
CY2015Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
246000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1360000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1612000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
4711000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3818000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7466000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
41000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1321000
CY2015Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
62000
CY2015Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
78000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
58000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
192000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7037000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
7922000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
218000
CY2015Q4 us-gaap Assets
Assets
165424000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2789000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1055000
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
456000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
161384000
CY2015Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
210000
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
149000
CY2015Q4 us-gaap Other Assets
OtherAssets
4000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
18000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
146000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161220000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4401000
CY2015Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
460000
CY2015Q4 wve Common Stock Votes Per Share
CommonStockVotesPerShare
1
CY2015Q4 wve Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
246000
CY2014Q3 wve Common Stock Voting Rights Percentage
CommonStockVotingRightsPercentage
0.50 pure
CY2014Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
1515596 shares
CY2014Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
9602000
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3551000
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.90
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1743014 shares
CY2013 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2500000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47000
CY2013 us-gaap Other Income
OtherIncome
43000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-3318000
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
135000
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3318000
CY2013 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-111000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-3574000
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
37000
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-74000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
102000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3183000
CY2013 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
135000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3648000
CY2013 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
2022000
CY2013 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
50000
CY2013 us-gaap Interest Paid Net
InterestPaidNet
90000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
86000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-330000
CY2013 us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-6000
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
248000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
60000
CY2013 us-gaap Operating Expenses
OperatingExpenses
3574000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-47000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3672000
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1920000
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-330000
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
78000
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1654000
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-152000
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
276000
CY2013 us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
-14000
CY2013 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
6172000
CY2013 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-330000
CY2013 wve Deferred Tax Assets Valuation Foreign Currency Translation
DeferredTaxAssetsValuationForeignCurrencyTranslation
160000
CY2013 wve Deferred Tax Assets Valuation Allowance Increase
DeferredTaxAssetsValuationAllowanceIncrease
864000
CY2013 wve Deferred Tax Assets Valuation Allowance Reversal
DeferredTaxAssetsValuationAllowanceReversal
379000
CY2013 wve Reimbursable Capital Expenditure
ReimbursableCapitalExpenditure
66000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4426000
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.34
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3911556 shares
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
590000
CY2014 us-gaap Other Income
OtherIncome
160000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-5229000
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-169000
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5229000
CY2014 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-12000
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5585000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12000
CY2014 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
15000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-5394000
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
261000
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
249000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
129000
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-14000
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5398000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5619000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2395000
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
84000
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5585000
CY2014 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-169000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5145000
CY2014 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3000
CY2014 us-gaap Interest Paid Net
InterestPaidNet
86000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
294000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
609000
CY2014 us-gaap Operating Expenses
OperatingExpenses
5394000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-257000
CY2014 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
9602000
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
124000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
84000
CY2014 us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-6000
CY2014 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
152000
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
14000
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
410000
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2999000
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9000
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
281000
CY2014 us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
-327000
CY2014 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
84000
CY2014 wve Deferred Tax Assets Valuation Foreign Currency Translation
DeferredTaxAssetsValuationForeignCurrencyTranslation
168000
CY2014 wve Stock Issued During Period Value Conversion Of Convertible Debt
StockIssuedDuringPeriodValueConversionOfConvertibleDebt
9602000
CY2014 wve Deferred Tax Assets Valuation Allowance Increase
DeferredTaxAssetsValuationAllowanceIncrease
1292000
CY2014 wve Collaboration Agreement Upfront Payment
CollaborationAgreementUpfrontPayment
152000
CY2014 wve Proceeds From Government Grant
ProceedsFromGovernmentGrant
34000
CY2014 wve Reimbursable Capital Expenditure
ReimbursableCapitalExpenditure
248000
CY2014 wve Proceeds From Government Grant Reimbursements For Property And Equipment
ProceedsFromGovernmentGrantReimbursementsForPropertyAndEquipment
319000
CY2014 wve Increase Decrease In Accrued Expenses For Deferred Offering Costs
IncreaseDecreaseInAccruedExpensesForDeferredOfferingCosts
72000
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-12527000
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.83
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0001631574
CY2015 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i>Concentration of Credit Risk</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Cash is a financial instrument that potentially subjects the Company to concentration of credit risk. The Company uses eight financial institutions to maintain its cash, all of which are high quality, accredited financial institutions and, accordingly, such funds are subject to minimal credit risk. The Company has not experienced any losses in such accounts and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. The Company has no financial instruments with off-balance sheet risk of loss.</p> </div>
CY2015 us-gaap Common Stock Voting Rights
CommonStockVotingRights
One vote for each ordinary share
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Registrant Name
EntityRegistrantName
WAVE LIFE SCIENCES LTD.
CY2015 us-gaap Revenue Recognition Services Licensing Fees
RevenueRecognitionServicesLicensingFees
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i>License Agreements and Patent Costs</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Costs associated with licenses of technology and patent costs are expensed as incurred and are generally included in research and development expense in the consolidated statements of operations.</p> </div>
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
The Company's board of directors and shareholders approved a 50-for-1 share split of the Company's outstanding ordinary and Series A preferred shares effective November 18, 2014. Additionally, on November 1, 2015, the Company's board of directors and shareholders approved a 4.0415917-for-1 share split of the Company's issued and outstanding ordinary shares, Series A preferred shares and Series B preferred shares.
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include the valuation of its Series A preferred shares on conversion of the related party notes payable, the valuation of the Company&#x2019;s ordinary shares prior to the initial public offering, the assumptions used to determine the fair value of share-based awards, the valuation allowance required for the Company&#x2019;s deferred tax assets, and determining uncertain tax positions and the related liabilities. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Actual results could differ from the Company&#x2019;s estimates.</p> </div>
CY2015 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement.
CY2015 dei Trading Symbol
TradingSymbol
WVE
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10501455 shares
CY2015 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
126000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1857000
CY2015 us-gaap Other Income
OtherIncome
155000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-19200000
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-15000
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19200000
CY2015 us-gaap Revenues
Revenues
152000
CY2015 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
86000
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11631000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
63000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-19298000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
56000
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
142000
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
62532000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-193000
CY2015 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
1055000
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19215000
CY2015 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19156000
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
0
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
4024000
CY2015 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
306000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
255000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
4024000
CY2015 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
38000
CY2015 us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
88000
CY2015 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-152000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
537000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
160172000
CY2015 us-gaap Operating Expenses
OperatingExpenses
19450000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2909000
CY2015 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
62532000
CY2015 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
268000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
175593000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9057000
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
36000
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11631000
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
267000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4024000
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10393000
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
8000
CY2015 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
101444000
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1648000
CY2015 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
594000
CY2015 us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
15000
CY2015 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
36000
CY2015 wve Deferred Tax Assets Valuation Foreign Currency Translation
DeferredTaxAssetsValuationForeignCurrencyTranslation
10000
CY2015 wve Deferred Tax Assets Valuation Allowance Increase
DeferredTaxAssetsValuationAllowanceIncrease
4818000
CY2015 wve Operating Loss Carryback Carried Forward To Reduce Future Taxable Income
OperatingLossCarrybackCarriedForwardToReduceFutureTaxableIncome
2365000
CY2015 wve Prior Written Notice Period For Termination
PriorWrittenNoticePeriodForTermination
P60D
CY2015 wve Proceeds From Government Grant
ProceedsFromGovernmentGrant
112000
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-400000
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
968000
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
CY2015 wve Reclassification Of Preferred Stock Value
ReclassificationOfPreferredStockValue
7874000
CY2015 wve Reimbursable Capital Expenditure
ReimbursableCapitalExpenditure
3000
CY2015 wve Proceeds From Government Grant Reimbursements For Property And Equipment
ProceedsFromGovernmentGrantReimbursementsForPropertyAndEquipment
3000
CY2015 wve Increase Decrease In Accrued Expenses For Deferred Offering Costs
IncreaseDecreaseInAccruedExpensesForDeferredOfferingCosts
1075000
CY2015 wve Minimum Percentage Of Issued And Outstanding Shares Required For Approval
MinimumPercentageOfIssuedAndOutstandingSharesRequiredForApproval
0.75 pure
CY2015 wve Maximum Number Of Directors On Board
MaximumNumberOfDirectorsOnBoard
7 Director
CY2015 wve Net Operating Losses Carryforward Available To Offset Future Federal Taxable Income
NetOperatingLossesCarryforwardAvailableToOffsetFutureFederalTaxableIncome
1871000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-3465000
CY2015Q1 us-gaap Revenues
Revenues
26000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
3491000
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-1717000
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
1292000
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-3700000
CY2015Q2 us-gaap Revenues
Revenues
126000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
3755000
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-1363000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
1354000
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-4936000
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
4990000
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-1749000
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
1780000
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.46
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-7099000
CY2015Q4 us-gaap Operating Expenses
OperatingExpenses
7214000

Files In Submission

Name View Source Status
0001193125-16-523890-index-headers.html Edgar Link pending
0001193125-16-523890-index.html Edgar Link pending
0001193125-16-523890.txt Edgar Link pending
0001193125-16-523890-xbrl.zip Edgar Link pending
d132744d10k.htm Edgar Link pending
d132744dex211.htm Edgar Link pending
d132744dex231.htm Edgar Link pending
d132744dex311.htm Edgar Link pending
d132744dex312.htm Edgar Link pending
d132744dex321.htm Edgar Link pending
d132744dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g132744g02p09.jpg Edgar Link pending
g132744g31u25.jpg Edgar Link pending
g132744g45d07.jpg Edgar Link pending
g132744g53n07.jpg Edgar Link pending
g132744g59h83.jpg Edgar Link pending
g132744g60e35.jpg Edgar Link pending
g132744g64l23.jpg Edgar Link pending
g132744g65o09.jpg Edgar Link pending
g132744g76s95.jpg Edgar Link pending
g132744g78w05.jpg Edgar Link pending
g132744g95a09.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wve-20151231.xml Edgar Link completed
wve-20151231.xsd Edgar Link pending
wve-20151231_cal.xml Edgar Link unprocessable
wve-20151231_def.xml Edgar Link unprocessable
wve-20151231_lab.xml Edgar Link unprocessable
wve-20151231_pre.xml Edgar Link unprocessable